Archive · 5 Oct 2026
Lords Mark Industries Shares Rise After UK Diagnostics Registration
Lords Mark Industries makes healthcare and diagnostic products.
The company said it registered its in-vitro diagnostics products with a UK regulator.
This could help it offer a wider range of healthcare products in the UK and nearby markets.
The company had earlier registered an AI-powered haemodialysis system there.
Its shares climbed during Monday’s trading after the update.
They finished the day nearly 2.57% higher.
The company plans to start selling its IVD products in the UK in December 2026.
That is about two months earlier than its previous plan.
Lords Mark Industries shares rose after the company announced a business milestone involving its in-vitro diagnostics portfolio.
The stock surged more than 4% during Monday’s trading session and closed nearly 2.57% higher.
The company registered its IVD portfolio with the UK’s Medicines and Healthcare products Regulatory Agency.
The registration is intended to support expansion across the UK and UK-allied markets.
Lords Mark Industries plans to begin commercial sales of its IVD products in the UK in December 2026, about two months earlier than previously scheduled.
- Who
- Lords Mark Industries Limited.
- What
- The company registered its IVD portfolio with the UK’s Medicines and Healthcare products Regulatory Agency and announced an earlier planned start for UK sales.
- When
- The share move was reported on Monday; planned commercial sales are to start in December 2026.
- Where
- The UK and UK-allied markets.
- Why
- The registration is intended to support the company’s expansion in healthcare and diagnostics across the UK and UK-allied markets.
- Company
- Lords Mark Industries Limited
- Regulator
- UK Medicines and Healthcare products Regulatory Agency (MHRA)
- New registration
- The company registered its in-vitro diagnostics (IVD) portfolio.
- Share performance
- Shares rose more than 4% during the session and closed nearly 2.57% higher on Monday.
- Planned UK sales
- Commercial sales of IVD products are planned to begin in December 2026.
- Schedule change
- The planned sales start is about two months earlier than the company’s previous schedule.
- Earlier registration
- The company had secured MHRA registration for its AI-powered haemodialysis system in September.